Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets open in 6 hours 38 minutes

S&P Futures
6,010.50
+23.50(+0.39%)
Dow Futures
44,634.00
+239.00(+0.54%)
Nasdaq Futures
20,955.00
+105.25(+0.50%)
Russell 2000 Futures
2,436.50
+22.90(+0.95%)
Crude Oil
70.51
-0.73(-1.02%)
Gold
2,668.90
-43.30(-1.60%)

PureTech Health plc (PRTC)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD

Follow

Visitors trend2W10W9M

22.55

+1.24

(+5.82%)

At close: 04:00PM EST

22.50

-0.05

(-0.22%)

After hours:

04:01PM EST

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	515.79M
Enterprise Value	37.76M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	879.56
Price/Book (mrq)	1.71
Enterprise Value/Revenue	348.82
Enterprise Value/EBITDA	-51.93

Trading Information

Stock Price History

Beta (5Y Monthly)	0.99
52-Week Change ³	7.38%
S&P500 52-Week Change ³	31.18%
52 Week High ³	34.00
52 Week Low ³	17.08
50-Day Moving Average ³	20.61
200-Day Moving Average ³	24.30

Share Statistics

Avg Vol (3 month) ³	6.02k
Avg Vol (10 day) ³	7.72k
Shares Outstanding ⁵	23.94M
Implied Shares Outstanding ⁶	27.39M
Float ⁸	156.6M
% Held by Insiders ¹	0.00%
% Held by Institutions ¹	0.12%
Shares Short (Oct 31, 2024) ⁴	6.28k
Short Ratio (Oct 31, 2024) ⁴	0.88
Short % of Float (Oct 31, 2024) ⁴	N/A
Short % of Shares Outstanding (Oct 31, 2024) ⁴	0.03%
Shares Short (prior month Sep 30, 2024) ⁴	7.03k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	-23,054.86%

Management Effectiveness

Return on Assets (ttm)	-13.39%
Return on Equity (ttm)	-22.07%

Income Statement

Revenue (ttm)	468k
Revenue Per Share (ttm)	0.02
Quarterly Revenue Growth (yoy)	-90.90%
Gross Profit (ttm)	N/A
EBITDA	-134.73M
Net Income Avi to Common (ttm)	-82.47M
Diluted EPS (ttm)	-3.00
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	500.42M
Total Cash Per Share (mrq)	2.09
Total Debt (mrq)	144.73M
Total Debt/Equity (mrq)	47.27%
Current Ratio (mrq)	3.68
Book Value Per Share (mrq)	1.32

Cash Flow Statement

Operating Cash Flow (ttm)	-120.8M
Levered Free Cash Flow (ttm)	-1.52M